(Q33373091)

26 July 2017

title

Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma (English)

1 reference

26 July 2017

Nozomi Niitsu

1

1 reference

26 July 2017

Masataka Okamoto

2

1 reference

26 July 2017

Naoto Tomita

3

1 reference

26 July 2017

Sadao Aoki

4

1 reference

26 July 2017

Jun-ichi Tamaru

5

1 reference

26 July 2017

Ikuo Miura

6

1 reference

26 July 2017

Masami Hirano

7

1 reference

26 July 2017

publication date

1 September 2006

1 reference

26 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Leukemia & Lymphoma

1 reference

26 July 2017

volume

47

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1908-1914

1 reference

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Individual Comparisons by Ranking Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600688313

10.1080/10428190600688313

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference